Skip to main content
Clinical Trials/CTRI/2022/02/040245
CTRI/2022/02/040245
Recruiting
Phase 3

Evaluation of comparative efficacy of Shunthyadi taila nasya versus Pippalayadi taila nasya along with Chitraka Haritaki systemically in the management of Ksavathu (Allergic Rhinitis).

mahatma gandhi ayurveda college0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
mahatma gandhi ayurveda college
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
mahatma gandhi ayurveda college

Eligibility Criteria

Inclusion Criteria

  • Aged \=19 years patients are included who have allergic rhinitis with following clinical Features like sneezing, runny nose, congestion or presence of 2 or more symptoms of allergic rhinitis (nasal congestion, rhinorrhea, nasal itching and sneezing)

Exclusion Criteria

  • Currently taking any of the following medications or cannot stop taking medication is unsuitable for this clinical trial.
  • 2\.Received treatments due to acute upper respiratory infections or sinusitis within the previous 4 weeks
  • 3\.Have anatomical obstructions or deformities of the nasal cavity or underwent nasal surgery within the previous 6 months
  • 4\.Diagnosed with malignant neoplasm, anemia, active pulmonary tuberculosis, infection, or other severe systemic disease. Has a past history of active respiratory diseases such as asthma
  • 5\.Patients with deviated nasal septum/ nasal polyps/ nasal growth/ adenoids/ asthma
  • 6\.Patients on steroids and immuno modulatory/ immunosuppression

Outcomes

Primary Outcomes

Not specified

Similar Trials